Effect of Bifidobacterium animalis spp. lactis Bl-04 on Rhinovirus-Induced Colds: A Randomized, Placebo-Controlled, Single-Center, Phase II Trial in Healthy Volunteers
Background: This study was designed to assess the efficacy of Bifidobacterium animalis ssp. lactis (Bl-04) for prevention of rhinovirus colds and to explore the interactions between the probiotic, the viral infection, the host response and the host microbiome. Methods: The effect of ingestion of the...
Guardado en:
Autores principales: | Ronald B. Turner, Liisa Lehtoranta, Ashley Hibberd, Sofia Männikkö, Bryan Zabel, Nicholas Yeung, Teppo Huttunen, Frank R. Burns, Markus J. Lehtinen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://doaj.org/article/18b3dc9b0b17493792a7f8b33741e9f9 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mechanism of Rhinovirus Immunity and Asthma
por: Zuqin Yang, et al.
Publicado: (2021) -
Corrigendum: Mechanism of Rhinovirus Immunity and Asthma
por: Zuqin Yang, et al.
Publicado: (2021) -
Human rhinovirus serotypes induces different immune responses
por: Ji Heui Kim, et al.
Publicado: (2021) -
Nasal microbiota clusters associate with inflammatory response, viral load, and symptom severity in experimental rhinovirus challenge
por: Markus J. Lehtinen, et al.
Publicado: (2018) -
Unsupervised machine learning reveals key immune cell subsets in COVID-19, rhinovirus infection, and cancer therapy
por: Sierra M Barone, et al.
Publicado: (2021)